Testimony on Stem Cell Research Oversight to California State Senate
By Marcy Darnovsky, PhD, Associate Director, Center for Genetics and Society
| 03. 09. 2005
Oversight Hearing on the Implementation of Proposition 71, the Stem Cell Research and Cures Act
To the Joint Hearing of the California Senate Subcommittee on Stem Cell Research Oversight, Senate Health Committee, and Assembly Health Committee:
Thank you for inviting my testimony today. My name is Marcy
Darnovsky. I'm the associate director of the Center for Genetics
and Society, an Oakland-based public interest organization that
works to encourage responsible uses and effective governance
of human biotechnologies. Together with other pro-choice public
interest groups, we support embryonic stem cell research and
public funding for it. Both before and since last November's
election, however, we've felt that we have had to raise a significant
number of concerns about Proposition 71 and the stem cell research
institute it established.
California now finds itself in a unique position with regards
to embryonic stem cell research. Nowhere in the world is this
research being as generously funded as it now is here, by the
people of this state. All of us hope that these funds will be
spent usefully and responsibly in order to develop treatments
and therapies, and to make them affordable and accessible to
the citizens of our...
Related Articles
By Hannah Devlin, The Guardian | 05.14.2024
Photo by Kind and Curious from Unsplash
When Great Ormond Street hospital (Gosh) published the results of its gene therapy trial for “bubble baby” syndrome it was hailed as a medical breakthrough. The treatment had a more than 95% success...
By Antonio Regalado, MIT Technology Review | 05.06.2024
It was a cool morning at the beef teaching unit in Gainesville, Florida, and cow number #307 was bucking in her metal cradle as the arm of a student perched on a stool disappeared into her cervix. The arm held...
By Gina Kolata, The New York Times | 05.06.2024
On Wednesday, Kendric Cromer, a 12-year-old boy from a suburb of Washington, became the first person in the world with sickle cell disease to begin a commercially approved gene therapy that may cure the condition.
For the estimated 20,000 people...
By Tomoko Otake, The Japan Times | 04.09.2024
A decade ago, researcher Haruko Obokata caused a sensation when she published two papers in the journal Nature, in which she claimed that she had discovered a way to create stem cells easily using the so-called STAP method.
With STAP...